Download Contact (.vcf)
New York Direct: 212.790.4598 General: 212.790.4500 Fax: 212.790.4545
Northwestern University School of Law, J.D., cum laude, 2008.
Northwestern University, M.S., Journalism, 2004.
Northwestern University, B.S., Journalism, magna cum laude, 2004.Kappa Tau Alpha National Journalism Honor Society.
U.S. Supreme Court
Michelle McGovern focuses her practice on a variety of regulatory and transactional matters for the healthcare industry. She assists hospitals, health systems, community health centers, managed care plans, insurers, pharmaceutical manufacturers and other healthcare clients with structuring and negotiating transactions and provides advice on complex regulatory and compliance issues affecting healthcare stakeholders.
Prior to joining Manatt, Ms. McGovern was an associate in the healthcare practice of a large, international law firm. She advised clients on healthcare regulatory, compliance and transactional matters, including issues related to the Medicare and Medicaid programs and fraud and abuse laws; helped to respond to government investigations and qui tam lawsuits; assisted with healthcare compliance audits; and provided counsel on tax-exempt entity structure and formation.
“Pharmacy Compounding Update: Regulators Search for the Right
Formula,” Bloomberg BNA’s Health Care
Policy Report, September 22, 2014.
Coauthor, “Data Security in Health Care: HIPAA Enforcement Trends,” New York Law Journal, July 14, 2014.
Coauthor, “The Legacy of Halifax: A New Stark Law Enforcement Landscape?” Bloomberg BNA’s Health Care Fraud Report, June 11, 2014.
Coauthor, “Inside HHS Rule on Test Results from HIPAA-Covered Labs,” Law360, February 24, 2014.
Author, New York State Bar Association State Bar News, Health Law Section Profile, “Get on the Omnibus: New HIPAA Rules for Business Associates,” November/December 2013
Author, “The Right Mix: Congressional Compromise on Compounding Results in a New Law,” Bloomberg BNA Pharmaceutical Law & Industry Report, December 2013
Author, “Prescription for Change: Proposed Regulation of Compounding Pharmacies,” Bloomberg BNA’s Pharmaceutical Law & Industry Report, September 27, 2013.
Author, “Pharmacy Compounding: What’s Ahead for Manufacturers,” PharmExec, June 1, 2013.
Author, “Proceed With Caution: Is Making a Disclosure Under the Self-Referral Disclosure Protocol Worth the Risk?” Benders Health Care Law Monthly, January 2012.
Author, “IDTFs – Closed to Patients, Open for Billing, and Ripe for Settlement Action,” Journal of Health Care Compliance, January-February 2012.
Coauthor, “Will the Shared Savings ACO Program Be Economically Viable For Its Participants? Calculating Savings or Losses – Putting the Pieces Together,” BNA’s Health Law Reporter, November 2011.
Author, “Compliance 2010: A Year in Review,” Journal of Health Care Compliance, March-April 2011.
Author, “Medicare Physician Self-Referral Disclosure Protocol: Will The Truth Set You Free?” Journal of Health Care Compliance, January 2011.
Coauthor, “Accountable Care Organizations: Navigating the Legal Landscape of Shared Savings and Coordinated Care,” J. Health & Life Sci. L., 2010.
Author, “Plugging Leaks: The Necessity of Distinguishing Whistleblowers and Wrongdoers in the Free Flow of Information Act,” U. Chi. L.J. 101, 2009.
Coauthor, “In re Bilski: A Death Knell for Business Method Patents?” New Jersey Lawyer Magazine, June 2009.
Coauthor, “Protecting Intellectual Property Rights in the Age of Screen Scraping,” Bloomberg.com, April 2009.
Coauthor, “New Jersey and In re Bilski – Not So Perfect Together!” New Jersey Law Journal, April 2009.
Author, “McConnell v. Federal Election Commission: The Problem of Eradicating Campaign Finance Corruption,” Rich. J.L. & Pub. Int., November 2008.
Admitted to practice in New York, Illinois, the District of Columbia and before the U.S. Supreme Court.
Member, American Health Lawyers Association.
© 2015 Manatt, Phelps & Phillips, LLP. All rights reserved.